• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDCA3 抑制通过 NF-κB/细胞周期蛋白 D1 信号失活和 p21 积累抑制前列腺癌进展。

Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.

机构信息

Department of Urology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China.

Department of Urology, Xishan People's Hospital of Wuxi City, Wuxi, Jiangsu 214000, P.R. China.

出版信息

Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8253. Epub 2021 Dec 31.

DOI:10.3892/or.2021.8253
PMID:34970697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8759108/
Abstract

Dysregulation of the cell cycle contributes to tumor progression. Cell division cycle‑associated 3 (CDCA3) is a known trigger of mitotic entry and has been demonstrated to be constitutively upregulated in tumors. It is therefore associated with carcinogenic properties reported in various cancers. However, the role of CDCA3 in prostate cancer is unclear. In the present study, western blotting and analysis of gene expression profiling datasets determined that CDCA3 expression was upregulated in prostate cancer and was associated with a poor prognosis. CDCA3 knockdown in DU145 and PC‑3 cells led to decreased cell proliferation and increased apoptosis, with increased protein expression levels of cleaved‑caspase3. Further experiments demonstrated that downregulated CDCA3 expression levels induced G0/G1 phase arrest, which was attributed to increased p21 protein expression levels and decreased cyclin D1 expression levels via the regulation of NF‑κB signaling proteins (NFκB‑p105/p50, IKKα/β, and pho‑NFκB‑p65). In conclusion, these results indicated that CDCA3 may serve a crucial role in prostate cancer and consequently, CDCA3 knockdown may be used as a potential therapeutic target.

摘要

细胞周期失调导致肿瘤进展。细胞分裂周期相关蛋白 3(CDCA3)是有丝分裂进入的已知触发因素,并且已被证明在肿瘤中持续上调。因此,它与各种癌症中报道的致癌特性有关。然而,CDCA3 在前列腺癌中的作用尚不清楚。在本研究中,通过 Western blot 分析和基因表达谱数据集分析,确定 CDCA3 在前列腺癌中表达上调,并与预后不良相关。在 DU145 和 PC-3 细胞中敲低 CDCA3 导致细胞增殖减少和细胞凋亡增加,同时 cleaved-caspase3 蛋白表达水平升高。进一步的实验表明,下调 CDCA3 表达水平诱导 G0/G1 期停滞,这归因于 p21 蛋白表达水平增加和细胞周期蛋白 D1 表达水平降低,通过调节 NF-κB 信号蛋白(NFκB-p105/p50、IKKα/β 和 pho-NF-κB-p65)。综上所述,这些结果表明 CDCA3 可能在前列腺癌中发挥重要作用,因此,CDCA3 敲低可能作为一种潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/5288f4eaede8/or-47-02-08253-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/dce4ab9b89d5/or-47-02-08253-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/3fabab5a1931/or-47-02-08253-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/e51599336985/or-47-02-08253-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/8cb65aba6ba8/or-47-02-08253-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/7b95cc471558/or-47-02-08253-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/5288f4eaede8/or-47-02-08253-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/dce4ab9b89d5/or-47-02-08253-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/3fabab5a1931/or-47-02-08253-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/e51599336985/or-47-02-08253-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/8cb65aba6ba8/or-47-02-08253-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/7b95cc471558/or-47-02-08253-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/8759108/5288f4eaede8/or-47-02-08253-g05.jpg

相似文献

1
Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.CDCA3 抑制通过 NF-κB/细胞周期蛋白 D1 信号失活和 p21 积累抑制前列腺癌进展。
Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8253. Epub 2021 Dec 31.
2
CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.CDCA3 通过调节结直肠癌细胞中 E2F1 的表达来介导 p21 依赖性增殖。
Int J Oncol. 2018 Nov;53(5):2021-2033. doi: 10.3892/ijo.2018.4538. Epub 2018 Aug 23.
3
CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.CDCA3 通过激活 NF-κB/细胞周期蛋白 D1 信号通路促进结直肠癌细胞增殖。
Biochem Biophys Res Commun. 2018 Jun 2;500(2):196-203. doi: 10.1016/j.bbrc.2018.04.034. Epub 2018 Apr 14.
4
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.吲哚 - 3 - 甲醇(I3C)可诱导前列腺癌细胞的细胞生长抑制、G1期细胞周期阻滞及凋亡。
Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365.
5
Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.大豆苷元通过下调人前列腺癌细胞中的Akt/细胞周期蛋白D1/细胞周期蛋白依赖性激酶4促进细胞周期停滞。
Cell Physiol Biochem. 2014;34(4):1351-8. doi: 10.1159/000366342. Epub 2014 Oct 2.
6
Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.细胞周期调控因子 CDCA3 的过表达通过促进细胞增殖来促进口腔癌的进展,同时防止 G1 期阻滞。
BMC Cancer. 2012 Jul 28;12:321. doi: 10.1186/1471-2407-12-321.
7
[The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].[雷洛昔芬对人前列腺癌细胞增殖抑制作用中丝裂原活化蛋白激酶级联反应的作用:一项体外实验]
Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):271-5.
8
Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.表没食子儿茶素没食子酸酯诱导结直肠癌细胞生长抑制与 cyclin D1 降解和 p21 诱导有关。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2051-60. doi: 10.1007/s00432-012-1276-1. Epub 2012 Jul 20.
9
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.噻唑烷二酮类药物通过PPARγ依赖性和PPARγ非依赖性途径调节人前列腺癌细胞中细胞周期蛋白的表达。
Cell Cycle. 2009 Jan 15;8(2):268-77. doi: 10.4161/cc.8.2.7584.
10
CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.CDCA3 是一种潜在的预后标志物,可促进胃癌中的细胞增殖。
Oncol Rep. 2019 Apr;41(4):2471-2481. doi: 10.3892/or.2019.7008. Epub 2019 Feb 12.

引用本文的文献

1
Tumor-associated long non-coding RNAs show variable expression across diffuse gliomas and effect on cell growth upon silencing in glioblastoma.肿瘤相关长链非编码RNA在弥漫性胶质瘤中呈现出可变表达,并且在胶质母细胞瘤中沉默后对细胞生长有影响。
Sci Rep. 2025 May 9;15(1):16220. doi: 10.1038/s41598-025-99984-9.
2
Rutin ameliorates stress-induced blood‒brain barrier dysfunction and cognitive decline via the endothelial HDAC1‒Claudin-5 axis.芦丁通过内皮组蛋白去乙酰化酶1-闭合蛋白-5轴改善应激诱导的血脑屏障功能障碍和认知能力下降。
Fluids Barriers CNS. 2025 Apr 2;22(1):35. doi: 10.1186/s12987-025-00639-8.
3
CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis.

本文引用的文献

1
[Retracted] KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.[已撤回]KIF4A通过转录激活CDCA3的表达促进膀胱癌的发展。
Int J Mol Med. 2023 Jul;52(1). doi: 10.3892/ijmm.2023.5265. Epub 2023 Jun 9.
2
Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.生物信息学分析鉴定了前列腺癌发生和转移中的枢纽基因。
Math Biosci Eng. 2021 Apr 6;18(4):3180-3196. doi: 10.3934/mbe.2021158.
3
HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer.
CDCA3-MYC正反馈回路通过ENO1介导的糖酵解促进膀胱癌进展。
J Exp Clin Cancer Res. 2025 Feb 20;44(1):63. doi: 10.1186/s13046-025-03325-7.
4
Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas.癌症中的环状RNA:在结直肠癌、胃癌、肝癌和肺癌中的作用、机制及治疗潜力
Discov Oncol. 2025 Jan 4;16(1):5. doi: 10.1007/s12672-025-01743-9.
5
Comprehensive bioinformatics analysis and cell line experiments revealed the important role of CDCA3 in sarcoma.全面的生物信息学分析和细胞系实验揭示了CDCA3在肉瘤中的重要作用。
Heliyon. 2024 Jun 16;10(13):e32785. doi: 10.1016/j.heliyon.2024.e32785. eCollection 2024 Jul 15.
6
COL1A1, mediated by m6A methylation of METTL3, facilitates oral squamous cell carcinoma cell growth and metastasis.由METTL3的m6A甲基化介导的COL1A1促进口腔鳞状细胞癌细胞的生长和转移。
Odontology. 2025 Jan;113(1):191-200. doi: 10.1007/s10266-024-00962-w. Epub 2024 Jun 20.
7
MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis.丝裂原活化蛋白激酶 14 作为关键基因调控银屑病中铁死亡角质形成细胞诱导的炎症反应和巨噬细胞 M1 极化。
Inflammation. 2024 Oct;47(5):1564-1584. doi: 10.1007/s10753-024-01994-8. Epub 2024 Mar 5.
8
CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation.环状 DNA 结合蛋白 2 通过促进 STUB1 介导的 PARK7 泛素化降解来调节铁死亡缓解肝纤维化。
J Gastroenterol. 2024 Mar;59(3):229-249. doi: 10.1007/s00535-023-02068-6. Epub 2024 Feb 3.
9
CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis.环状 RNA SFMBT2 通过 miR-1305/SALL4 轴在肺腺癌中发挥致癌作用。
Biochem Genet. 2024 Oct;62(5):3485-3503. doi: 10.1007/s10528-023-10611-6. Epub 2023 Dec 21.
10
Prognostic value of cell division cycle-associated protein-3 in prostate cancer.细胞分裂周期相关蛋白 3 在前列腺癌中的预后价值。
Medicine (Baltimore). 2023 Sep 8;102(36):e34655. doi: 10.1097/MD.0000000000034655.
高迁移率族蛋白B1(HMGB1)通过HMGB1/肿瘤坏死因子受体1(TNFR1)/核因子κB(NF-κB)轴促进去势抵抗性前列腺癌的肿瘤进展和侵袭。
Am J Cancer Res. 2021 May 15;11(5):2215-2227. eCollection 2021.
4
Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells.NF-κB信号通路的反馈激活导致前列腺癌细胞对EZH2抑制剂产生适应性耐药。
Cancer Cell Int. 2021 Apr 1;21(1):191. doi: 10.1186/s12935-021-01897-w.
5
EZH2-TROAP Pathway Promotes Prostate Cancer Progression TWIST Signals.EZH2-TROAP通路通过TWIST信号促进前列腺癌进展。
Front Oncol. 2021 Feb 22;10:592239. doi: 10.3389/fonc.2020.592239. eCollection 2020.
6
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.CDCA5 通过影响 ERK 信号通路促进前列腺癌的进展。
Oncol Rep. 2021 Mar;45(3):921-932. doi: 10.3892/or.2021.7920. Epub 2021 Jan 4.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.全面分析 CDCAs 在头颈部鳞状细胞癌中的表达和预后。
PLoS One. 2020 Jul 27;15(7):e0236678. doi: 10.1371/journal.pone.0236678. eCollection 2020.
9
Downregulation of CDCA3 expression inhibits tumor formation in pancreatic cancer.下调 CDCA3 表达抑制胰腺癌肿瘤形成。
Neoplasma. 2020 Nov;67(6):1223-1232. doi: 10.4149/neo_2020_200411N388. Epub 2020 Jul 23.
10
Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.长链非编码 RNA SNHG12 通过上调肾细胞癌中的 CDCA3 促进肿瘤进展和舒尼替尼耐药。
Cell Death Dis. 2020 Jul 8;11(7):515. doi: 10.1038/s41419-020-2713-8.